This website uses cookies to keep track of login sessions and for internal Piwik Statistics. See our Legal Notes for details.This website uses cookies, learn more
IT systems at our distribution centre, ECACC, are being updated to improve and streamline order processing. Limited processing of orders has resumed. Find out more
European Bank for Induced pluripotent Stem Cells (EBiSC)
The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality tools for new medicines development.
In the initial phase (2014-2017), EBiSC has been designed to address the increasing demand for quality-controlled, disease-relevant, research-grade iPSC lines, data and cell services.
EBiSC launched a second project phase starting at March 2019 to become a self-sustainable central iPSC hub pooling EU resources to structure the iPSC landscape in terms of quality, consistency, available data, standards and licensing agreements.
What EBiSC2 offers iPSC-related projects:
Support in legal and ethical aspects
Advice on iPSC generation and handling
Make your iPSC lines sustainable via a deposit in the EBiSC catalogue
Available EBiSC2 services upon demand:
QC panel testing according to established EBiSC guidelines
Cell line commissioning (iPSC generation, differentiation and gene-editing)
Backup your iPSC lines in the ISO-certified, monitored EBiSC bank
Pre-defined disease-specific cell panels for screening purposes
...while ensuring clear IP rights and visibility of your project.
News
May 17th, 2022 - Press release
The FAIRplus and EBiSC2 projects are joining forces to improve how ‘FAIR’ standards (Findability, Accessibility, Interoperability and Reusability) can be applied to human induced Pluripotent Stem Cell (iPSC) line data . The joint effort will improve how iPSC line data can be made more findable, standardised and reusable for researchers. Read more
Sep 10th, 2020 - EBiSC2 at one glance
An EBiSC2 infographic is now published, summarizing at one glance the implications and benefits of deposition, the ethical and legal governance sourcing EBiSC lines and how iPSC lines can be deposited into and purchased from EBiSC. Read more
Feb 17th, 2020 - Press release
A new cohort of iPSC lines available from EBiSC will accelerate research into Huntington’s disease. Read more